Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Abaxis, Inc. (NASDAQ: ABAX).

Full DD Report for ABAX

You must become a subscriber to view this report.


Recent News from (NASDAQ: ABAX)

WeissLaw LLP Investigates Abaxis Inc.
NEW YORK , May 17, 2018 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Abaxis Inc. ("ABAX" or the "Company") (NASDAQ: ABAX) in connection with the proposed acquisition of the Company by Zoetis Inc....
Source: PR Newswire
Date: May, 17 2018 17:34
Today's Research Reports on Stocks to Watch: Abaxis, Inc. and Cesca Therapeutics
NEW YORK, NY / ACCESSWIRE / May 17, 2018 / After dismal first quarter results this week and an announcement of pricing of a public offering of 9,166,667 units, shares of Cesca Therapeutics were clobbered. The stock closed down over 33% on Wednesday. Shares of Abaxis hit an all-time high how...
Source: ACCESSWIRE IA
Date: May, 17 2018 08:10
SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Abaxis, Inc. - ABAX
BALA CYNWYD, PA / ACCESSWIRE / May 16, 2018 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Abaxis, Inc. ("Abaxis" or "the Company") (NASDAQ: ABAX News) for possible breaches of fiduciary duty and other violations...
Source: ACCESSWIRE IA
Date: May, 16 2018 21:33
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Regarding Whether the Sale of Abaxis, Inc. to Zoetis Inc. is Fair to Shareholders
The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Abaxis, Inc. (“Abaxis” or the “Company”) (NASDAQ:ABAX) stock  prior to May 16, 2018 . You are hereby notified  that Levi & Ko...
Source: Business Wire
Date: May, 16 2018 16:34
Abaxis Inc. to be Acquired by Zeotis
In an announcement made on Wednesday, the human and veterinary medical equipment company Abaxis Inc. (NASDAQ:ABAX) will be acquired by the animal health company Zoetis Inc. (NYSE:ZTS). Zoetis will purchase Abaxis for a nearly $2 billion USD, or $83.00 per share, in cash and the agreemen...
Source: MicroSmallCap
Date: May, 16 2018 14:18
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Abaxis, Inc. (ABAX) on Behalf of Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. is investigating potential claims on behalf of Abaxis, Inc. (NASDAQ: ABAX) stockholders concerning the proposed acquisition of the company by Zoetis Inc. (NYSE: ZTS). Our investigation concerns whether Abaxis’s board of directors failed to adequatel...
Source: Business Wire
Date: May, 16 2018 13:46
ABAXIS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
Rigrodsky & Long, P.A.: Do you own shares of Abaxis, Inc. (NASDAQ GS: ABAX )? Did you purchase any of your shares prior to May 16, 2018? Do you think the proposed buyout is fair? Do you want to discuss your rights? Rigrodsky & Long, P.A. announc...
Source: Business Wire
Date: May, 16 2018 13:20
Midday Gainers / Losers (05/16/2018)
Gainers: IHT +50% . BLNK +36% . EBIO +21% . GEMP +18% . VNET +18% . FSI +16% . ABAX +16% . BBOX +13% . ASNA +14% . NSPR +14% . More news on: Innsuites Hospitality Trust, Blink Charging Co., Eleven Biotherapeutics, Inc., Stocks on the move, , Read more ....
Source: SeekingAlpha
Date: May, 16 2018 13:00
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Abaxis, Inc.
NEW YORK , May 16, 2018 /PRNewswire/ -- Rowley Law PLLC is investigating potential claims against Abaxis, Inc. (NASDAQ: ABAX) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Zoetis Inc. Stockholders will receive $83.00 f...
Source: PR Newswire
Date: May, 16 2018 11:25
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Abaxis, Inc. to Zoetis Inc. is Fair to Shareholders
The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Abaxis, Inc. (“Abaxis” or the “Company”) (NASDAQ: ABAX) stock  prior to May 16, 2018 . You are hereby notified  that Levi & K...
Source: Business Wire
Date: May, 16 2018 10:28

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-1783.2683.7283.7783.001,106,452
2017-04-0348.6548.5648.8748.29126,303
2017-03-3148.2548.5048.9548.0995,562
2017-03-3048.7548.3349.22547.86182,478
2017-03-2948.1348.6948.8047.7479,371

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-07-3118,78541,05345.7579Short
2018-07-30132,050140,27094.1399Short
2018-07-276,37712,85549.6072Short
2018-07-263,6658,88741.2400Short
2018-07-255,53118,63129.6871Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ABAX.


About Abaxis, Inc. (NASDAQ: ABAX)

Logo for Abaxis, Inc. (NASDAQ: ABAX)

Not available

 

Contact Information

 

 

Current Management

  • Clinton H. Severson / President, CEO
  • Donald J. Stewart / CFO

Current Share Structure

  • Market Cap: $1,608,153,300 - 05/11/2018
  • Issue and Outstanding: 22,698,000 - 02/07/2018

 


Recent Filings from (NASDAQ: ABAX)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 17 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: May, 17 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: May, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 16 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: May, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 26 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 26 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 27 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 14 2018

 

 


Daily Technical Chart for (NASDAQ: ABAX)

Daily Technical Chart for (NASDAQ: ABAX)


Stay tuned for daily updates and more on (NASDAQ: ABAX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: ABAX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ABAX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of ABAX and does not buy, sell, or trade any shares of ABAX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/